serena williams glp-1 ro serves up Super Bowl ad starring Serena Williams Super Bowl LX
Description
It wins by owning an adjacent metabolic indication the incumbents have not closed out
Other GLP-1 receptor agonist products are used off-label for weight loss
How It Works Activates both GLP-1 and GIP receptors for a broader metabolic impact Reduces appetite and increases satiety through two hormonal pathways Enhances insulin sensitivity more aggressively than GLP-1 alone Supports reduction of visceral fat the deep abdominal fat most strongly associated with metabolic disease Improves blood sugar regulation through a dual insulin-stimulating mechanism Clinical Results In the SURMOUNT-1 trial, Tirzepatide produced average weight loss of up to 20% of body weight outperforming Semaglutide in head-to-head comparisons
Many pharmacies and GP surgeries provide sharps disposal services
For some people, this can lead to nausea, bloating, reflux, or constipation
That figure sounds frightening until you place it next to other ways of losing the same amount of weight, where the proportions land in a similar range
